Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest update is out from Shanghai Heartcare Medical Technology Corp. Ltd. Class H ( (HK:6609) ).
Shanghai Heartcare Medical Technology Corp. Ltd. announced significant changes in its board and supervisory committee to enhance corporate governance and meet new gender diversity requirements. These changes include the appointment of Ms. Zhang Kun to the Nomination Committee and Mr. Liu Baiwei as the new Employee Representative Supervisor, replacing Mr. Xue Zongyu, who resigned due to personal commitments.
More about Shanghai Heartcare Medical Technology Corp. Ltd. Class H
Shanghai Heartcare Medical Technology Corp. Ltd. operates in the medical technology industry, focusing on developing innovative medical solutions. The company is incorporated in the People’s Republic of China and is listed on the Hong Kong Stock Exchange.
YTD Price Performance: 44.87%
Average Trading Volume: 51,152
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.23B
Find detailed analytics on 6609 stock on TipRanks’ Stock Analysis page.